
In an already troubled week for Valeant Pharmaceuticals, the company has now announced that its group chairman and executive vice …
Johnson & Johnson has announced that Sheri McCoy, vice chairman of the executive committee, will leave the company on April …
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

